GlaxoSmithKline Pharmaceuticals

NSE Announcements on GlaxoSmithKline

Posted by : MMB Messenger
Price when posted : [GlaxoSmithKline - BSE:Rs. 1172.00 NSE:Rs. 1175.20 when posted]

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 45715 lacs for quarter ending on 31-MAR-2009 against Rs. 41811 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 14327 lacs for the quarter ending on 31-MAR-2009 against Rs. 12127 lacs for the quarter ending on 31-MAR-2008....

bay a share of glaxosmithkline or not

Posted by : jdosvd
Price when posted : BSE: Rs 1165.05 ( 2.81 % ), NSE: Rs. 1054.10 ( -10.45 % )

Yes stock is over 10% up and I feel should go gradually upto 1300 levels.Stock is a laggard though and will go up like a tortise in its own time after haveing a few good naps on the way!...

Acquisition in U S

Posted by : rvk41
Price when posted : BSE: Rs 1123.00 ( 0.65 % ), NSE: Rs. 1054.10 ( -10.45 % )

British-based pharmaceuticals firm GlaxoSmithKline PLC is in talks to buy privately-owned US skincare specialist Stiefel Laboratories, a source familiar with the situation said on Sunday

It was unclear whether a deal for the firm would be reached, the source said. The source declined to be identified because the talks are not public.

The Wall Street Journal earlier reported that a $3 billion deal for Stiefel, part-owned by buyout firm Blackstone Group, is expected to be announced on Monday. The Journal also said there is still a chance it could fall apart.

Stiefel is the world`s largest independent dermatology company and is viewed as a potentially attractive asset for major drugmakers, industry experts have said.

The Journal said the business had drawn interest from a number of major drug companies, including Johnson & Johnson and Novartis AG.

For information,with regards
rvk41...

BSE Announcements on GlaxoSmithKline

Posted by : MMB Messenger
Price when posted : [GlaxoSmithKline - BSE:Rs. 1106.00 NSE:Rs. 1175.20 when posted]

GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 28, 2009, inter alia, to consider, approval of unaudited financial results for the quarter ended March 31, 2009 (Q1)....

Partnership in S A

Posted by : rvk41
Price when posted : BSE: Rs 1052.35 ( 0.67 % ), NSE: Rs. 1054.10 ( -10.45 % )

GlaxoSmithKline Plc plans to take a significant stake in Aspen Pharmacare Holdings Ltd to strengthen its partnership with the South African drugmaker, people familiar with the situation said.
The move, which could be announced in the next week or so, underlines Glaxo’s commitment to growing in emerging markets as part of a strategy to diversify its business

For information,with regards
rvk41...

bay a share of glaxosmithkline or not

Posted by : jdosvd
Price when posted : BSE: Rs 1047.80 ( 0.57 % ), NSE: Rs. 1039.55 ( -11.69 % )

Yes one can enter at these rates,I do not think it will go below 990....

bay a share of glaxosmithkline or not

Posted by : Guest
Price when posted : BSE: Rs 1040.15 ( -3.26 % ), NSE: Rs. 1071.80 ( -8.95 % )

is it right time to invest in glxo smithkline at CMP of 1038?...

bay a share of glaxosmithkline or not

Posted by : jdosvd
Price when posted : BSE: Rs 1042.00 ( -3.09 % ), NSE: Rs. 1071.80 ( -8.95 % )

Yes it is soft and now at 1038,I had exited cum dividend expecting the stock to come to 1110 levels,however now waiting to re-enter below 1000 if it gets there....

bay a share of glaxosmithkline or not

Posted by : psgs
Price when posted : BSE: Rs 1075.20 ( -2.42 % ), NSE: Rs. 1071.80 ( -8.95 % )

i too agree with you. its a safe cash rich company. good for investment even in current bad markets. but it doesn`t move anywhere. it just hangs on in one place. its a bargain buy now as it is at 1070, ex-div price should have been 1110. 40 rupees discount can be got now if one buys at 1070 level.

swamy.
...

bay a share of glaxosmithkline or not

Posted by : jdosvd
Price when posted : BSE: Rs 1153.00 ( -1.44 % ), NSE: Rs. 1169.60 ( -0.64 % )

Yes,today is the time to buy the share now at 1155 and below as today is the last date for Rs 40 dividend giving almost 3.5% dividend yield.Results were good and will continue to be ok.Bonus etc is uncertain but at these rates one could also get 10-20% capital appreciation in the short/medium term.
P.S. I entered today at 1152....

bay a share of glaxosmithkline or not

Posted by : bmd
Price when posted : BSE: Rs 1180.10 ( -0.14 % ), NSE: Rs. 1183.55 ( 0.55 % )

when glaxosmithkline bonus due in year.i want to bay share...

move beyond 1300

Posted by : Guest
Price when posted : BSE: Rs 1180.00 ( -0.17 % ), NSE: Rs. 1182.55 ( 0.46 % )

Can we purchase at this price for say 1-2year outlook,looking at dividend and also steady in the turbulent times,and also they say there are planing to acquire india pharma companies....

move beyond 1300

Posted by : psgs
Price when posted : BSE: Rs 1173.75 ( -1.47 % ), NSE: Rs. 1189.40 ( 1.04 % )

no big deal. looks like there is some huge extra ordinary income :) ...

move beyond 1300

Posted by : Guna
Price when posted : BSE: Rs 1196.70 ( 0.51 % ), NSE: Rs. 1197.55 ( 1.74 % )

Now the results are out, can glaxo move beyond 1300?...